
Biomarker Holds Promise in COPD Treatment
A team led by U-M researchers discovered that a noninvasive imaging biomarker can identify small airway damage in COPD patients.
A team led by U-M researchers discovered that a noninvasive imaging biomarker can identify small airway damage in COPD patients.
The annual American Thoracic Society International Conference wrapped up this week. Here’s a look at some of the newest research and stories from this year’s conference.
Sending a patient to an intensive care unit after a heart attack, or a flare-up of heart failure or COPD, may sound like the best option. But it’s not always the case.
It’s the third-leading cause of death in the United States, but compared to other chronic diseases, COPD research funding is low and patients’ access to care is poor.
A new study finds smokers who haven’t been diagnosed with COPD may still experience COPD-like symptoms. This begs the question: Should the diagnostic requirements for COPD change?